COMPASS Pathways plc (CMPS) Form 10-Q — Aug 5, 2026
COMPASS Pathways reported a Q2 2026 net loss of $253.8 million versus $38.4 million a year ago, but the deterioration was overwhelmingly a $205.6 million non-cash fair-value charge on warrant liabilities; the underlying operating loss was $52.4 million as G&A ramped for commercial preparedness. Cash nearly tripled to $433.3 million from $149.6 million at year-end, fueled by the February 2026 offering ($140.5 million net), full exercise of the 2025 ADS warrants ($203.2 million), a $50 million Hercules term loan draw, and ATM sales. Management now expects existing cash to fund operations into 2028.
Key figures
- Eps
- -$1.88 (Q2 2026) vs -$0.41 (Q2 2025); -$1.33 (six months 2026)
- Net Income
- -$253.8 million (Q2 2026) vs -$38.4 million (Q2 2025); -$162.6 million (six months 2026) vs -$56.3 million (six months 2025)
- Total Debt
- 50727000
- Total Assets
- 504561000
- Cash Position
- 433295000
- Shares Outstanding
- 138476822
- Cash runway
- into 2028
- Q2 2026 ga expense
- 23197000
- Q2 2026 rd expense
- 29175000
- Accumulated deficit
- 985200000
- Warrant liabilities
- 337459000
- Hercules loan funded
- 50000000
- Hercules loan capacity
- 150000000
- Q3 2026 to date proceeds
- 31700000
- Pipe warrants outstanding
- 11809700
- Effective interest rate pct
- 12.9
- Six month operating cash burn
- 88242000
- Feb 2026 offering net proceeds
- 140500000
- Prefunded warrants outstanding
- 23848829
- Ads warrant exercise net proceeds
- 203200000
- Pipe warrants potential gross proceeds
- 105800000
Price after filing
Close on the filing date to close N calendar days later (from $11.80). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.